1. Home
  2. BGI vs VVOS Comparison

BGI vs VVOS Comparison

Compare BGI & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Birks Group Inc.

BGI

Birks Group Inc.

HOLD

Current Price

$0.69

Market Cap

18.6M

Sector

N/A

ML Signal

HOLD

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$1.19

Market Cap

15.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGI
VVOS
Founded
1879
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.6M
15.1M
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
BGI
VVOS
Price
$0.69
$1.19
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.25
AVG Volume (30 Days)
18.4K
106.3K
Earning Date
12-05-2025
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.07
EPS
N/A
N/A
Revenue
N/A
$15,031,000.00
Revenue This Year
N/A
$31.42
Revenue Next Year
N/A
$49.82
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.91
52 Week Low
$0.56
$1.19
52 Week High
$1.57
$7.40

Technical Indicators

Market Signals
Indicator
BGI
VVOS
Relative Strength Index (RSI) 36.04 33.14
Support Level $0.65 N/A
Resistance Level $0.95 $1.50
Average True Range (ATR) 0.06 0.11
MACD 0.00 0.00
Stochastic Oscillator 25.63 1.56

Price Performance

Historical Comparison
BGI
VVOS

About BGI Birks Group Inc.

Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: